Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

Background Concerns have emerged regarding a higher risk of stent thrombosis after drug-
eluting stent (DES) implantation, especially in the setting of ST-segment elevation …

Background: Previous meta-analyses have investigated the relative safety and efficacy
profiles of different types of drug-eluting stents (DES) and bare-metal stents (BMS); however …

Aims To evaluate safety and effectiveness of early generation drug-eluting stents (DES)
compared with bare-metal stents (BMS) in patients with ST-segment elevation myocardial …

Background: Some concerns still have not been resolved about the long-term safety of drug-
eluting stents (DES) in patients with acute STEMI. Objectives: The aim of this study was to …

Background—Late adverse events such as very late stent thrombosis (VLST) or late target-
lesion revascularization (TLR) after first-generation sirolimus-eluting stents (SES) …

Background—The efficacy and safety of drug-eluting stents (DES) in patients with ST-
segment–elevation myocardial infarction (STEMI) is controversial. Consequently, DES …

The use of drug-eluting stents (DESs) in primary percutaneous coronary intervention (PPCI)
has shown early benefit over bare-metal stents (BMSs) in decreasing adverse cardiac …

Objectives: The aim of the current study was to compare everolimus-eluting stents (EES)
with sirolimus-eluting stents (SES) in patients undergoing primary angioplasty. Background …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …